Aevi Genomic Medicine (GNMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Operating Expenses | 6,436 | 15,367 | 6,917 | 7,848 | 6,197 |
| Operating Income | -6,436 | -15,367 | -6,917 | -7,848 | -6,197 |
| Other Income | -21 | -1,148 | 835 | -1,073 | 5 |
| Pre-tax Income | -6,457 | -16,515 | -6,082 | -8,921 | -6,192 |
| Income Tax | 6 | 6 | 4 | 1 | 4 |
| Net Income Continuous | -6,463 | -16,521 | -6,086 | -8,922 | -6,196 |
| Net Income | $-6,463 | $-16,521 | $-6,086 | $-8,922 | $-6,196 |
| EPS Basic Total Ops | -0.16 | -0.66 | -0.24 | -0.36 | -0.31 |
| EPS Basic Continuous Ops | -0.15 | -0.66 | -0.24 | -0.36 | -0.31 |
| EPS Diluted Total Ops | -0.15 | -0.66 | -0.28 | -0.36 | -0.30 |
| EPS Diluted Continuous Ops | -0.15 | -0.66 | -0.24 | -0.36 | -0.31 |
| EBITDA(a) | $-6,377 | $-15,310 | $-6,836 | $-7,805 | $-6,134 |